Description
Afanat™ is a quality assured generic of Gilotrif® (also known as Xovoltib®) used to treat metastatic non–small cell lung cancer (NSCLC) with non–resistant epidermal growth factor receptor (EGFR) mutations. It’s also used to treat metastatic squamous NSCLC progressing after platinum-based chemotherapy. It’s produced in a US FDA approved factory in India.
Strength : 20 Mg
Bottle Size : 28 Tablets
Active Ingredients : Afatinib
Produced by Natco Pharma Ltd®